Export

EN
FR
Amikacin
Essential medicine status
Section:
6. Anti-infective medicines 6.2. Antibacterials 6.2.5. Antituberculosis medicines
ATC codes: J01GB06
EMLc
Indication
Multi-drug resistant Mycobacterium tuberculosis ICD11 code: ML32.00
INN
Amikacin
Medicine type
Chemical agent
Antibiotic groups
ACCESS
List type
Core (EML)
(EMLc)
Additional notes
Medicines for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control.
Formulations
Parenteral > General injections > unspecified: 250 mg per mL in 2 mL vial (as sulfate)
EML status history
First added in 1999 (TRS 895)
Changed in 2007 (TRS 950)
Changed in 2009 (TRS 958)
Changed in 2021 (TRS 1035)
Changed in 2023 (TRS 1049)
Changed in 2025 (TRS 1064)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Amikacin
DrugBank
Amikacin
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended the transfer of listings for medicines for multi-drug resistant tuberculosis from the complementary to the core list of the EML and EMLc.